Xiao-xi Lv
State Key Laboratory Of Bioactive Substance And Function Of Natural Medicines, Chinese Academy Of Medical Sciences & Peking Union Medical College
Beijing, 100050, China
Beijing, 100050, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Author Correction: ID1 expressing macrophages support cancer cell stemness and limit CD8+ T cell infiltration in colorectal cancer.
Journal: Nature communications
Published: February 09, 2026
Targeting Degradation of the Transcription Factor C/EBPβ Reduces Lung Fibrosis by Restoring Activity of the Ubiquitin-Editing Enzyme A20 in Macrophages.
Journal: Immunity
Published: June 25, 2025
Corrigendum to "Disruption of the EGFR-SQSTM1 interaction by a stapled peptide suppresses lung cancer via activating autophagy and inhibiting EGFR signaling" [Cancer Lett. 474 (2020) 23-35].
Journal: Cancer letters
Published: January 01, 2025
Wild-type IDH1 maintains NSCLC stemness and chemoresistance through activation of the serine biosynthetic pathway.
Journal: Science translational medicine
Published: December 13, 2023
Mesaconine alleviates doxorubicin-triggered cardiotoxicity and heart failure by activating PINK1-dependent cardiac mitophagy.
Journal: Frontiers in pharmacology
Published: December 07, 2022
TRIB3 reduces CD8+ T cell infiltration and induces immune evasion by repressing the STAT1-CXCL10 axis in colorectal cancer.
Journal: Science translational medicine
Published: January 05, 2022
The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis.
Journal: Immunity
Published: October 13, 2021
Autophagic Flux Detection: Significance and Methods Involved.
Journal: Advances in experimental medicine and biology
Published: July 14, 2021
The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis.
Journal: Immunity
Published: August 28, 2020
Resistomycin attenuates triple-negative breast cancer progression by inhibiting E3 ligase Pellino-1 and inducing SNAIL/SLUG degradation.
Journal: Signal transduction and targeted therapy
Published: May 22, 2020
Last Updated: 09/26/2026